VACCINE AGAINST NEWCASTLE DISEASE

VACCINE AGAINST NEWCASTLE DISEASE

FIELD: medicine; biotechnologies. ^ SUBSTANCE: vaccine contains virus material from "La-Sota" strain, saccharose, enzymatic peptone, casein, aerosil AM-1-300 and resin KB-4P-2. At that virus material from "La-Sota" strain used in vaccine is suspension from whole hen's eggs w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RAD'KOV VJACHESLAV NIKOLAEVICH, GRIGORENKO ARKADIJ IL'ICH, SHUL'GINA ZHANNA LEONIDOVNA, GOREVA IRINA PROKOF'EVNA, RUDENKO TAT'JANA VLADISLAVOVNA, SMOLENSKIJ VLADIMIR IVANOVICH
Format: Patent
Sprache:eng ; rus
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RAD'KOV VJACHESLAV NIKOLAEVICH
GRIGORENKO ARKADIJ IL'ICH
SHUL'GINA ZHANNA LEONIDOVNA
GOREVA IRINA PROKOF'EVNA
RUDENKO TAT'JANA VLADISLAVOVNA
SMOLENSKIJ VLADIMIR IVANOVICH
description FIELD: medicine; biotechnologies. ^ SUBSTANCE: vaccine contains virus material from "La-Sota" strain, saccharose, enzymatic peptone, casein, aerosil AM-1-300 and resin KB-4P-2. At that virus material from "La-Sota" strain used in vaccine is suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation. Vaccine also additionally contains alpha-tocopherol with the following ratio of components, wt %: suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation - 10.73-12.47, saccharose - 4.16-4.60, enzymatic peptone - 2.50-3.06, casein - 0.83-1.53, alpha-tocopherol - 0.04-0.08, aerosil AM-1-300 - 1.00-2.00, resin KB-4P-2 - the rest. ^ EFFECT: high immunogenicity, harmlessness for bird and ecological safety for servicing personnel. ^ 4 tbl, 5 ex
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2347584C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2347584C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2347584C13</originalsourceid><addsrcrecordid>eNrjZFAMc3R29vRzVXB0d_T0Cw5R8HMNd3YMDvFxVXDxDHZ1DHblYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxQaFGxibmphYmzobGRCgBAM8PId4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VACCINE AGAINST NEWCASTLE DISEASE</title><source>esp@cenet</source><creator>RAD'KOV VJACHESLAV NIKOLAEVICH ; GRIGORENKO ARKADIJ IL'ICH ; SHUL'GINA ZHANNA LEONIDOVNA ; GOREVA IRINA PROKOF'EVNA ; RUDENKO TAT'JANA VLADISLAVOVNA ; SMOLENSKIJ VLADIMIR IVANOVICH</creator><creatorcontrib>RAD'KOV VJACHESLAV NIKOLAEVICH ; GRIGORENKO ARKADIJ IL'ICH ; SHUL'GINA ZHANNA LEONIDOVNA ; GOREVA IRINA PROKOF'EVNA ; RUDENKO TAT'JANA VLADISLAVOVNA ; SMOLENSKIJ VLADIMIR IVANOVICH</creatorcontrib><description>FIELD: medicine; biotechnologies. ^ SUBSTANCE: vaccine contains virus material from "La-Sota" strain, saccharose, enzymatic peptone, casein, aerosil AM-1-300 and resin KB-4P-2. At that virus material from "La-Sota" strain used in vaccine is suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation. Vaccine also additionally contains alpha-tocopherol with the following ratio of components, wt %: suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation - 10.73-12.47, saccharose - 4.16-4.60, enzymatic peptone - 2.50-3.06, casein - 0.83-1.53, alpha-tocopherol - 0.04-0.08, aerosil AM-1-300 - 1.00-2.00, resin KB-4P-2 - the rest. ^ EFFECT: high immunogenicity, harmlessness for bird and ecological safety for servicing personnel. ^ 4 tbl, 5 ex</description><language>eng ; rus</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090227&amp;DB=EPODOC&amp;CC=RU&amp;NR=2347584C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090227&amp;DB=EPODOC&amp;CC=RU&amp;NR=2347584C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RAD'KOV VJACHESLAV NIKOLAEVICH</creatorcontrib><creatorcontrib>GRIGORENKO ARKADIJ IL'ICH</creatorcontrib><creatorcontrib>SHUL'GINA ZHANNA LEONIDOVNA</creatorcontrib><creatorcontrib>GOREVA IRINA PROKOF'EVNA</creatorcontrib><creatorcontrib>RUDENKO TAT'JANA VLADISLAVOVNA</creatorcontrib><creatorcontrib>SMOLENSKIJ VLADIMIR IVANOVICH</creatorcontrib><title>VACCINE AGAINST NEWCASTLE DISEASE</title><description>FIELD: medicine; biotechnologies. ^ SUBSTANCE: vaccine contains virus material from "La-Sota" strain, saccharose, enzymatic peptone, casein, aerosil AM-1-300 and resin KB-4P-2. At that virus material from "La-Sota" strain used in vaccine is suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation. Vaccine also additionally contains alpha-tocopherol with the following ratio of components, wt %: suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation - 10.73-12.47, saccharose - 4.16-4.60, enzymatic peptone - 2.50-3.06, casein - 0.83-1.53, alpha-tocopherol - 0.04-0.08, aerosil AM-1-300 - 1.00-2.00, resin KB-4P-2 - the rest. ^ EFFECT: high immunogenicity, harmlessness for bird and ecological safety for servicing personnel. ^ 4 tbl, 5 ex</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAMc3R29vRzVXB0d_T0Cw5R8HMNd3YMDvFxVXDxDHZ1DHblYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxQaFGxibmphYmzobGRCgBAM8PId4</recordid><startdate>20090227</startdate><enddate>20090227</enddate><creator>RAD'KOV VJACHESLAV NIKOLAEVICH</creator><creator>GRIGORENKO ARKADIJ IL'ICH</creator><creator>SHUL'GINA ZHANNA LEONIDOVNA</creator><creator>GOREVA IRINA PROKOF'EVNA</creator><creator>RUDENKO TAT'JANA VLADISLAVOVNA</creator><creator>SMOLENSKIJ VLADIMIR IVANOVICH</creator><scope>EVB</scope></search><sort><creationdate>20090227</creationdate><title>VACCINE AGAINST NEWCASTLE DISEASE</title><author>RAD'KOV VJACHESLAV NIKOLAEVICH ; GRIGORENKO ARKADIJ IL'ICH ; SHUL'GINA ZHANNA LEONIDOVNA ; GOREVA IRINA PROKOF'EVNA ; RUDENKO TAT'JANA VLADISLAVOVNA ; SMOLENSKIJ VLADIMIR IVANOVICH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2347584C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2009</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RAD'KOV VJACHESLAV NIKOLAEVICH</creatorcontrib><creatorcontrib>GRIGORENKO ARKADIJ IL'ICH</creatorcontrib><creatorcontrib>SHUL'GINA ZHANNA LEONIDOVNA</creatorcontrib><creatorcontrib>GOREVA IRINA PROKOF'EVNA</creatorcontrib><creatorcontrib>RUDENKO TAT'JANA VLADISLAVOVNA</creatorcontrib><creatorcontrib>SMOLENSKIJ VLADIMIR IVANOVICH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RAD'KOV VJACHESLAV NIKOLAEVICH</au><au>GRIGORENKO ARKADIJ IL'ICH</au><au>SHUL'GINA ZHANNA LEONIDOVNA</au><au>GOREVA IRINA PROKOF'EVNA</au><au>RUDENKO TAT'JANA VLADISLAVOVNA</au><au>SMOLENSKIJ VLADIMIR IVANOVICH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VACCINE AGAINST NEWCASTLE DISEASE</title><date>2009-02-27</date><risdate>2009</risdate><abstract>FIELD: medicine; biotechnologies. ^ SUBSTANCE: vaccine contains virus material from "La-Sota" strain, saccharose, enzymatic peptone, casein, aerosil AM-1-300 and resin KB-4P-2. At that virus material from "La-Sota" strain used in vaccine is suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation. Vaccine also additionally contains alpha-tocopherol with the following ratio of components, wt %: suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation - 10.73-12.47, saccharose - 4.16-4.60, enzymatic peptone - 2.50-3.06, casein - 0.83-1.53, alpha-tocopherol - 0.04-0.08, aerosil AM-1-300 - 1.00-2.00, resin KB-4P-2 - the rest. ^ EFFECT: high immunogenicity, harmlessness for bird and ecological safety for servicing personnel. ^ 4 tbl, 5 ex</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2347584C1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title VACCINE AGAINST NEWCASTLE DISEASE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T19%3A45%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RAD'KOV%20VJACHESLAV%20NIKOLAEVICH&rft.date=2009-02-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2347584C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true